CARDIUM THERAPEUTICS
Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to partnering, commercialization and other economic monetizations. Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing and cardiovascular indications, and the To Go Brands nutraceutical supplement business.
CARDIUM THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.cardiumthx.com
Total Employee:
11+
Status:
Active
Contact:
8584361001
Email Addresses:
[email protected]
Total Funding:
750 K USD
Technology used in webpage:
Domain Not Resolving Google Maps
Similar Organizations
Origin
Origin is a privately held, clinical-stage biotechnology company.
Albumedix
Albumedix is a science-driven, biotechnology company
Aten Therapeutics
Aten Therapeutics is an innovative biotechnology company
Califia Bio
Califia Bio’s expertise is in hit generation, lead optimization and preclinical development.
Cognigen
Since opening our doors in 1992, we’ve partnered with leading pharmaceutical and biotechnology companies
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
EKR Therapeutics
EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.
Elfamed
Elfamed is a regenerative medicine and biotechnology company
Factor Therapeutics Ltd.
Factor Therapeutics Ltd. is an Australian biotechnology company
Healshape
Healshape is a 3D bioprinting regenerative medecine company.
Heart Health
Heart Health is a company focused on biotechnology.
January Therapeutics
January Therapeutics is a San Diego-based biotechnology company.
Ontario Institute For Regenerative Medicine
Ontario Institute For Regenerative Medicine is a biotechnology emergency medicine company.
ReCyte Therapeutics
ReCyte Therapeutics is a regenerative medicine company focused on stem cell technology.
SciStem Therapeutics
SciStem Therapeutics is an early stage regenerative medicine company.
Current Advisors List
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-08-11 | Tissue Repair Company | Tissue Repair Company acquired by Cardium Therapeutics | N/A |
| 2006-03-09 | INNERCOOL Therapies | INNERCOOL Therapies acquired by Cardium Therapeutics | N/A |
Official Site Inspections
http://www.cardiumthx.com
- Host name: 172.67.166.205
- IP address: 172.67.166.205
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cardium Therapeutics"
Cardium Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 8584361001 Cardium is focused on the acquisition and strategic development of new and …See details»
CARDIUMTHERAPEUTICS - PTCA
To the World Health Organization, by 2020 heart disease and stroke will become the leading causes of both death and disability worldwide, with the number of fatalities projected to …See details»
Cardium Therapeutics, Inc. | LinkedIn
Cardium Therapeutics, Inc. | 435 followers on LinkedIn. Cardium Therapeutics is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and ...See details»
Cardium Therapeutics, Inc. Overview | SignalHire Company Profile
Organization Website: cardiumthx.com : Contact Email: [email protected]: Cardium Therapeutics... industries Biotech: Headquarters Location: 12255 El Camino Real, …See details»
Cardium Therapeutics Inc., Christopher J. Reinhard,
[email protected]: Phone: 1-858-436-1000: Website: www.cardiumthx.com Fax: 1-858-436-1001: Summary ; Executive Details ; Financial Details ; Board Members ; Stock …See details»
Cardium Therapeutics Inc. - SlideShare
Cardium Therapeuitcs (NYSE MKT: CXM) is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that …See details»
Cardium Therapeutics - VentureRadar
Cardium Therapeutics VentureRadar profile. Find out more about Cardium Therapeutics, Stem Cells, DNA, RNA and Peptide Therapies.See details»
Cardium Therapeutics (CXM) Corporate Profile | OTC …
Cardium Therapeutics Website Get connected with Cardium Therapeutics. Request More CXM Information View all articles and comment in the CXM blog. About Cardium Therapeutics. Cardium is a health sciences and regenerative …See details»
Cardium Becomes Taxus Cardium Pharmaceuticals Group In …
SAN DIEGO, March 17, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has changed its corporate name and business to Taxus Cardium …See details»
Tissue Repair Company - Crunchbase Company Profile & Funding
Organization. Tissue Repair Company . Connect to CRM . Save . Summary. People. Technology. Signals & News. ... Contact Email [email protected]; Phone Number (858) …See details»
Cardium Therapeutics, Inc. (CXM) and the Generx Strategy
Feb 20, 2013 Cardium Therapeutics’ lead clinical development product candidate is Generx, a DNA-based angiogenic growth factor therapeutic being developed for the potential treatment …See details»
Cardium Announces Positive Interim Phase 3 Clinical Data …
SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc. (Trading Symbol: CRXM) will report today at the Biotechnology Industry Organization's 2014 …See details»
Cardium Therapeutics, Inc.’s (CXM) Generx® Addresses Global …
Oct 25, 2013 Among other opportunities in its portfolio, the company’s lead clinical development product candidate, Generx®, is being developed to treat patients with advanced coronary …See details»
Cardium Therapeutics, Inc. And Aries Ventures Announce Merger ...
Oct 20, 2005 Cardium Therapeutics, Inc. And Aries Ventures Announce Merger, Completion Of $30 Million Financing And Strategic Acquisition Of Cardiovascular Product Portfolio - read this …See details»
Articles about Cardium Therapeutics, Inc. - BioSpace
Jun 12, 2014 Cardium Therapeutics, Inc. To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 Biotechnology Industry Organization (BIO) …See details»
Cardium's Generx Advances to Phase 3 Following Meeting with FDA
SAN DIEGO, CA – December 7, 2006 – Cardium Therapeutics, Inc (OTCBB: CDTP) announced that Generx™ (alferminogene tadenovec) is to be advanced to a Phase 3 clinical trial in …See details»
www.Cardiumthx.com - Cardium Therapeutics, Innovative Bio
In the United States, Cardiumthx.com is ranked 258,584, with an estimated 3,962 monthly visitors a month. Click to view other data about this site. Cardiumthx.com. Go to website. Cardiumthx …See details»
Cardium Announces Strategic Collaboration And Funding With …
SAN DIEGO, March 3, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Trading Symbol: CRXM) reported that it has entered into a strategic collaboration and funding arrangement with …See details»
Cardium Therapeutics, Inc. Provides Updated Summary Of
Apr 4, 2006 Cardium Therapeutics, Inc. Provides Updated Summary Of Generx Clinical Program For Potential Treatment Of Coronary Heart Disease - read this article along with other careers …See details»
Cardium Announces Strategic Focus On Advanced Regenerative …
SAN DIEGO, Jan. 27, 2014 /PRNewswire/ -- Cardium Therapeutics Inc. (Ticker Symbol: CRXM) reported on the Company's strategic focus on its two advanced regenerative medicine …See details»